Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Drake

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 5, 2013
A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonistsW M Drake, C E Stiles, T A Howlett, et al.
European Journal of Endocrinology|December 16, 1998
Dose-related effects of growth hormone on IGF-I and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemiaW M Drake, F Miraki, A Siddiqi, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 12, 2001
Multisite bone ultrasound measurement on North American female reference populationW M Drake, M McClung, C F Njeh, et al.
Hormone Research|October 10, 2002
Influence of growth hormone on accretion of bone massJ P Monson, W M Drake, P V Carroll, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegalyP J Trainer, W M Drake, L A Perry, et al.
Clinical Endocrinology|July 17, 2003
The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegalyC Parkinson, A J Whatmore, A P Yates, et al.
Hormone Research in Paediatrics|March 2, 2010
SDHD-related chromaffin tumours: disease localisation to genetic dysfunctionU Srirangalingam, B Khoo, M Matson, et al.
Endocrine-Related Cancer|August 17, 2022
The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomasN Tufton, R J Hearnden, D M Berney, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndromeJ Newell-Price, D G Morris, W M Drake, et al.
Endocrinology, Diabetes & Metabolism Case Reports|August 15, 2015
Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronismS Hussain, E Panteliou, D M Berney, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|November 5, 2013
A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonistsW M Drake, C E Stiles, T A Howlett, et al.
European Journal of Endocrinology|December 16, 1998
Dose-related effects of growth hormone on IGF-I and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemiaW M Drake, F Miraki, A Siddiqi, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 12, 2001
Multisite bone ultrasound measurement on North American female reference populationW M Drake, M McClung, C F Njeh, et al.
Hormone Research|October 10, 2002
Influence of growth hormone on accretion of bone massJ P Monson, W M Drake, P V Carroll, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegalyP J Trainer, W M Drake, L A Perry, et al.
Clinical Endocrinology|July 17, 2003
The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegalyC Parkinson, A J Whatmore, A P Yates, et al.
Hormone Research in Paediatrics|March 2, 2010
SDHD-related chromaffin tumours: disease localisation to genetic dysfunctionU Srirangalingam, B Khoo, M Matson, et al.
Endocrine-Related Cancer|August 17, 2022
The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomasN Tufton, R J Hearnden, D M Berney, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndromeJ Newell-Price, D G Morris, W M Drake, et al.
Endocrinology, Diabetes & Metabolism Case Reports|August 15, 2015
Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronismS Hussain, E Panteliou, D M Berney, et al.
Pageof 9